Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

Cancer researchers push to relax rules for clinical trials

US government examines whether criteria for participating in drug studies unnecessarily exclude some people.
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed  Google Scholar

Nearly 20% of publicly funded cancer clinical trials in the United States fail because investigators are unable to enrol enough participants. Yet patients and their physicians often grow frustrated when they encounter the sometimes insurmountable requirements to join a study.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 556, 12-13 (2018)

doi: https://doi.org/10.1038/d41586-018-03355-6

References

  1. Gerber, D. E., Laccetti, A. L., Xuan, L., Halm, E. A. & Pruitt, S. L. J. Natl Cancer Inst. 106, dju302 (2014).

    Article  PubMed  CAS  Google Scholar 

  2. Kim, E. S. et al. J. Clin. Oncol. 35, 3737–3744 (2017).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links